(Q45772570)

15 December 2017

title

Effects of non-nucleoside inhibitors of human immunodeficiency virus type 1 in cell-free recombinant reverse transcriptase assays (English)

1 reference

15 December 2017

author name string

Z Gu

1

1 reference

15 December 2017

Y Quan

2

1 reference

15 December 2017

Z Li

3

1 reference

15 December 2017

E J Arts

4

1 reference

15 December 2017

M A Wainberg

5

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 December 1995

1 reference

15 December 2017

Journal of Biological Chemistry

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

15 December 2017

volume

270

1 reference

15 December 2017

page(s)

31046-31051

1 reference

15 December 2017

issue

52

1 reference

15 December 2017

Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.52.31046

3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.52.31046

Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.52.31046

Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.52.31046

A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.52.31046

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.52.31046

Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.52.31046

Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.52.31046

Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.52.31046

Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.52.31046

Resistance to 2',3'-dideoxycytidine conferred by a mutation in codon 65 of the human immunodeficiency virus type 1 reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.52.31046

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.52.31046

Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.52.31046

Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.52.31046

BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.52.31046

Inhibition of human immunodeficiency virus type 1 reverse transcriptase by the 5'-triphosphate beta enantiomers of cytidine analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.52.31046

Mutated K65R recombinant reverse transcriptase of human immunodeficiency virus type 1 shows diminished chain termination in the presence of 2',3'-dideoxycytidine 5'-triphosphate and other drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.52.31046

Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.52.31046

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.52.31046

Lack of synergy in the inhibition of HIV-1 reverse transcriptase by combinations of the 5'-triphosphates of various anti-HIV nucleoside analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.52.31046

Mechanism of resistance of human immunodeficiency virus type 1 to 2',3'-dideoxyinosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.52.31046

Inhibition of human immunodeficiency virus type 1 integrase by 3'-azido-3'-deoxythymidylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.52.31046

Structure of HIV-1 RT/TIBO R 86183 complex reveals similarity in the binding of diverse nonnucleoside inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.52.31046

HIV resistance to reverse transcriptase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.52.31046

Characterization of HIV-1 strains isolated from patients treated with TIBO R82913.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.52.31046

Isolation of drug-resistant variants of HIV-1 from patients on long-term zidovudine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.52.31046

Nevirapine synergistically inhibits HIV-1 replication in combination with zidovudine, interferon or CD4 immunoadhesin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.52.31046

21 January 2018

Identifiers

DOI

10.1074/JBC.270.52.31046

1 reference

15 December 2017

PubMed ID

8537362

1 reference

15 December 2017